Mobia Medical, Inc. Common Stock Total Liabilities
Mobia Medical, Inc. Common Stock total liabilities. Based on the latest financial reports, Mobia Medical, Inc. Common Stock (MOBI) has total liabilities worth $22.68 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See MOBI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Mobia Medical, Inc. Common Stock (2024–2025)
Total liabilities of Mobia Medical, Inc. Common Stock from 2024 to 2025. This chart illustrates how Mobia Medical, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Mobia Medical, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Mobia Medical, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Advanced Enzyme Technologies Limited
NSE:ADVENZYMES
|
India | Rs-16.83 Billion |
|
IndoStar Capital Finance Limited
NSE:INDOSTAR
|
India | Rs-37.83 Billion |
|
Zhejiang Tailin Bioengineering Co Ltd
SHE:300813
|
China | CN¥140.46 Million |
|
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
|
China | CN¥101.07 Million |
|
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
|
China | CN¥232.13 Million |
|
Viva Biotech Holdings
F:VB0
|
Germany | €2.98 Billion |
|
Shanghai Ace Invest&Dvlp Co
SHG:603329
|
China | CN¥2.08 Billion |
|
Shaanxi Broadcast & TV Network Intermediary Group Co Ltd
SHG:600831
|
China | CN¥8.94 Billion |
Liability Composition Analysis (2024–2025)
This chart breaks down Mobia Medical, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MOBI current and non-current assets.
Liquidity & Leverage Metrics
Mobia Medical, Inc. Common Stock Total Liabilities Ratios Explained
Mobia Medical, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mobia Medical, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mobia Medical, Inc. Common Stock (2024–2025)
The table below shows the annual total liabilities of Mobia Medical, Inc. Common Stock from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $198.92 Million | +55.25% |
| 2024-12-31 | $128.13 Million | -- |
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more